Nang Kuang Pharmaceutical Co., Ltd. - Laporan Laba Rugi (TTM)

Nang Kuang Pharmaceutical Co., Ltd.
TW ˙ TWSE
NT$ 38.45 ↓ -0.05 (-0.13%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Nang Kuang Pharmaceutical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,826 1,755 1,698 1,718 1,758 1,780 1,733 1,763 1,789 1,940 2,138 2,189 2,235 2,150 2,106 2,094 2,137 2,200 2,251 2,280
Change (%) -3.91 -3.24 1.20 2.33 1.23 -2.66 1.74 1.47 8.48 10.17 2.38 2.11 -3.79 -2.07 -0.55 2.05 2.94 2.32 1.31
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,163 1,158 1,126 1,150 1,175 1,186 1,159 1,157 1,164 1,246 1,359 1,403 1,439 1,395 1,382 1,400 1,427 1,452 1,455 1,443
Change (%) -0.45 -2.73 2.14 2.13 0.91 -2.27 -0.16 0.63 6.99 9.14 3.21 2.59 -3.10 -0.90 1.31 1.89 1.78 0.18 -0.78
% of Revenue 63.70 65.99 66.34 66.95 66.82 66.60 66.87 65.62 65.08 64.19 63.59 64.10 64.40 64.86 65.64 66.86 66.76 66.01 64.63 63.30
Gross Operating Profit 663 597 572 568 583 594 574 606 625 695 778 786 796 756 724 694 710 748 796 837
Change (%) -9.98 -4.21 -0.65 2.75 1.88 -3.43 5.57 3.07 11.24 12.02 0.94 1.26 -5.04 -4.24 -4.09 2.35 5.29 6.47 5.13
% of Revenue 36.30 34.01 33.66 33.05 33.18 33.40 33.13 34.38 34.92 35.81 36.41 35.90 35.60 35.14 34.36 33.14 33.24 33.99 35.37 36.70
SG&A 237 212 213 209 210 206 203 204 212 229 242 254 258 332 332 331 338 268 278 287
Change (%) -10.72 0.33 -1.90 0.57 -1.83 -1.51 0.61 3.99 8.06 5.34 5.13 1.50 28.60 0.07 -0.36 2.17 -20.61 3.67 3.24
% of Revenue 13.00 12.08 12.53 12.14 11.93 11.57 11.71 11.58 11.87 11.82 11.30 11.61 11.54 15.42 15.76 15.79 15.81 12.19 12.35 12.59
R&D 153 160 157 146 143 134 137 140 143 144 147 149 154 164 167 169 167 169 170 180
Change (%) 4.16 -1.72 -7.07 -1.75 -6.58 2.31 2.32 1.62 0.90 2.00 1.41 3.51 6.58 2.06 1.07 -1.30 1.37 0.16 6.00
% of Revenue 8.40 9.11 9.25 8.49 8.16 7.53 7.91 7.96 7.97 7.41 6.86 6.80 6.89 7.63 7.95 8.08 7.82 7.70 7.54 7.89
OpEx 1,554 1,530 1,496 1,505 1,528 1,526 1,499 1,501 1,519 1,619 1,748 1,806 1,851 1,890 1,881 1,900 1,932 1,890 1,902 1,910
Change (%) -1.56 -2.20 0.60 1.54 -0.17 -1.77 0.17 1.18 6.57 7.96 3.32 2.51 2.12 -0.47 1.00 1.66 -2.17 0.67 0.41
% of Revenue 85.10 87.18 88.11 87.59 86.91 85.70 86.49 85.16 84.92 83.42 81.75 82.50 82.83 87.92 89.35 90.74 90.39 85.90 84.52 83.77
Operating Income 272 225 202 213 230 254 234 262 270 322 390 383 384 260 224 194 205 310 348 370
Change (%) -17.32 -10.26 5.65 7.95 10.53 -8.02 11.77 3.13 19.21 21.27 -1.83 0.23 -32.30 -13.73 -13.47 5.86 51.09 12.33 6.20
% of Revenue 14.90 12.82 11.89 12.41 13.09 14.30 13.51 14.84 15.08 16.58 18.25 17.50 17.17 12.08 10.65 9.26 9.61 14.10 15.48 16.23
Interest Expense -4 -4 -4 -4 -4 -4 -4 -4 -4 -5 -5 -6 -6 -7 -7 -6 -6 -6 -6 -8
Change (%) -0.51 -6.35 -6.86 -6.38 0.34 4.41 8.54 12.16 7.70 6.14 7.69 13.49 14.44 -1.42 -11.91 -11.05 -0.34 17.25 17.51
% of Revenue -0.24 -0.25 -0.24 -0.22 -0.20 -0.20 -0.21 -0.23 -0.25 -0.25 -0.24 -0.25 -0.28 -0.33 -0.34 -0.30 -0.26 -0.25 -0.29 -0.33
Net Income 216 183 165 176 192 196 192 213 242 352 405 423 395 198 159 111 122 243 261 269
Change (%) -15.10 -9.91 6.59 9.11 2.06 -1.92 10.58 13.72 45.54 15.04 4.45 -6.62 -49.77 -19.80 -30.47 10.39 99.28 7.12 2.99
% of Revenue 11.83 10.45 9.73 10.25 10.93 11.02 11.10 12.06 13.52 18.14 18.94 19.32 17.67 9.23 7.56 5.28 5.72 11.06 11.58 11.78

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista